Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity

• Main Authors: Wei Deng (Author), YanBo Huang (Author), HaiShang Li (Author), ChiWei Chen (Author), YueWei Lin (Author), Min Wang (Author), HuaSheng Huang (Author), Teng Liu (Author), QiuLi Qin (Author), Yang Shao (Author), YongChao Tang (Author), Kai Yuan (Author), JinYong Ding (Author), LiangLiang Xu (Author), YongXian Li (Author), ShunCong Zhang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Osteoporosis is a type of systematic metabolic bone disease caused by the decrease in osteogenic activity or excessive resorption of bone with the relative enhancement of osteoclast function. As osteoporosis seriously affects the quality of patients' life, effective drugs are needed...